世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

乳房病変局在化市場：タイプ別（ワイヤー、放射性同位元素（ROLL、RSL）、磁気、電磁波による局在化）、用途別（乳房生検、乳腺摘出術）、エンドユーザー別（病院、画像診断センター、外来手術センター）-2028年までの世界予測


Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL, RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy, Lumpectomy), End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) - Global Forecast to 2028

世界の乳房病変局在化市場は、2023年の3億米ドルから2028年には4億米ドルに達し、予測期間中の年平均成長率は6.9％と予測されている。マンモグラフィによる乳がん検診の増加や画像技術の改良の増加により、触知不... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2023年7月17日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		270 308 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界の乳房病変局在化市場は、2023年の3億米ドルから2028年には4億米ドルに達し、予測期間中の年平均成長率は6.9％と予測されている。マンモグラフィによる乳がん検診の増加や画像技術の改良の増加により、触知不能な臨床的潜因性乳房病変の発見が増加し、周術期の局在化が必要となっている。
近年、患者の安全性向上、効率化、医療費削減を目的とした乳房病変局在化装置の技術的進歩がいくつか見られる。

"乳房病変局在化市場では乳房生検分野が大きなシェアを占める"

2022年、乳房病変局在化市場では乳房生検セグメントがより大きなシェアを占めた。このセグメントの大きなシェアは、世界中で乳房生検を選択する患者が増加していること、検診プログラムで発見される触知不能な乳房病変の割合が増加していること、乳がん検診プログラムの数が増加していること、乳がんの罹患率が増加していること、早期がん発見に対する意識が高まっていることに起因している。

"電磁ローカライゼーションは予測期間中に最も高いCAGRで成長する"

タイプ別では、電磁波ローカライゼーションセグメントが予測期間中に最も高いCAGRで成長すると推定される。このセグメントの高成長は、手術遅延の減少、患者満足度の向上、最適な手術計画、放射性成分の不要などの要因によるものと考えられる。乳房局在化法の分野における最近の発展は、電磁波を使用して乳房病変を局在化する技術的に高度な局在化法の出現である。

"アジア太平洋地域は予測期間中に最も高いCAGRで成長する"

2022年、アジア太平洋地域は予測期間中最高のCAGRで成長する。この市場の成長を促す主な要因は、乳がん有病率の上昇、医療費の増加、APAC諸国における乳がん早期発見のための啓発プログラムの増加である。さらに、乳がん研究に対する政府支出の増加、資金提供の増加もAPACの市場成長を後押ししている。

乳房病変局在化市場における主要参入企業のプロファイルの内訳：供給側

- 企業タイプ別ティア1：55％、ティア2：30％、ティア3：15
- 役職別Cレベル-28%、病院ディレクター＆マネージャー-33%、その他-39
- 地域別北米35％、欧州20％、アジア太平洋地域30％、中東9％、中南米6

乳房病変局在化市場における主要参入企業のプロファイルの内訳：需要側

- エンドユーザー別：病院：55%、クリニック：32%、外来手術センター：13
- 役職別医師35％、病院長・管理職27％、クリティカルケア専門医22％、その他16
- 地域別北米17％、欧州39％、アジア太平洋28％、中東8％、中南米8

乳房病変局在化市場の主要企業は、Hologic, Inc.（米国）、Becton, Dickinson and Company（米国）、Merit Medical Systems（米国）、Leica Biosystems Nussloch GmbH（米国）、Argon Medical Devices（米国）などである。
調査範囲
この調査レポートは、乳房病変局在化市場を分析し、タイプ、用途、エンドユーザー、地域などの様々なセグメントに基づいて、市場規模と今後の成長可能性を推定することを目的としています。また、市場で入手可能な様々な乳房病変局在化の製品ポートフォリオマトリックスも掲載しています。また、本レポートでは、本市場における主要企業の競合分析も提供しており、企業プロフィール、製品提供、主要市場戦略などを掲載しています。
レポート購入の理由
本レポートは、乳房病変局在化市場全体およびサブセグメントの収益数の最も近い近似値に関する情報を提供し、本市場の市場リーダー/新規参入者に役立ちます。本レポートは、利害関係者が競争状況を理解し、自社の事業をより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。
本レポートは、以下のポイントに関する洞察を提供します：

- 乳房病変局在化市場の成長に影響を与える主な促進要因（乳がんの罹患率の増加、高齢化率の増加、乳がんの早期発見に関する意識の高まり）、阻害要因（規制当局の承認手続きの不確実性）、機会（新興国は高い成長の可能性を提供し、技術的に高度な局在化手順の採用が増加）、課題（腫瘍医の不足）の分析
- 製品開発/イノベーション：乳房病変局在化市場における今後の技術、研究開発活動、新製品発売に関する詳細な洞察
- 市場開発：タイプ別、用途別、エンドユーザー別、地域別の有利な新興市場に関する包括的情報。
- 市場の多様化：世界の乳房病変局在化市場における新製品や製品の強化、成長地域、最近の開発、投資に関する詳細な情報。
- 競合評価：Hologic, Inc.（米国）、Becton, Dickinson and Company（米国）、Merit Medical Systems（米国）、Leica Biosystems Nussloch GmbH（米国）、Argon Medical Devices（米国）など、世界の乳房病変局在化市場における主要企業の市場シェア、成長戦略、製品提供、競合リーダーシップマッピング、能力を詳細に評価します。

ページTOPに戻る


目次

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.3 INCLUSIONS AND EXCLUSIONS 37
1.4 STUDY SCOPE 38
1.4.1 MARKETS COVERED 38
FIGURE 1 MARKET SEGMENTATION 38
1.4.2 YEARS CONSIDERED 38
1.5 CURRENCY CONSIDERED 39
1.6 STAKEHOLDERS 39
1.7 SUMMARY OF CHANGES 39
1.8 RECESSION IMPACT: BREAST LESION LOCALIZATION MARKET 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 2 RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY DATA 43
FIGURE 3 PRIMARY SOURCES 44
2.1.2.1 Key data from primary sources 45
2.1.2.2 Key industry insights 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46
2.2 MARKET SIZE ESTIMATION 47
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 48
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: HOLOGIC, INC. 48
FIGURE 8 BREAST LESION LOCALIZATION MARKET: REVENUE SHARE ANALYSIS OF FOUR KEY COMPANIES (2022) 49
FIGURE 9 BREAST LESION LOCALIZATION MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
2.2.1 MARKET SEGMENT ASSESSMENT (BY TYPE, USAGE, AND END USER) 52
FIGURE 11 TOP-DOWN APPROACH 52
2.2.2 GEOGRAPHICAL MARKET ASSESSMENT (BY REGION AND COUNTRY) 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 12 DATA TRIANGULATION METHODOLOGY 53
2.4 STUDY ASSUMPTIONS 54
2.5 RISK ASSESSMENT 54
TABLE 1 BREAST LESION LOCALIZATION MARKET: RISK ASSESSMENT ANALYSIS 54
2.6 RESEARCH LIMITATIONS 55
2.6.1 METHODOLOGY-RELATED LIMITATIONS 55
2.6.2 SCOPE-RELATED LIMITATIONS 55
3 EXECUTIVE SUMMARY 56
FIGURE 13 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 56
FIGURE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 15 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 58
FIGURE 16 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 17 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2023 VS. 2028 (THOUSAND PROCEDURES) 59
FIGURE 18 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 19 BREAST LESION LOCALIZATION MARKET, BY END USER, 2023 VS. 2028 (THOUSAND PROCEDURES) 60
FIGURE 20 BREAST LESION LOCALIZATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 61
FIGURE 21 GEOGRAPHICAL ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (PROCEDURES) 62
FIGURE 22 GEOGRAPHICAL ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (VALUE) 63
4 PREMIUM INSIGHTS 65
4.1 BREAST LESION LOCALIZATION MARKET OVERVIEW 65
FIGURE 23 RISING AWARENESS ABOUT BREAST CANCER AND INCREASING GOVERNMENT INITIATIVES GLOBALLY TO DRIVE MARKET 65
4.2 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE 66
FIGURE 24 WIRE LOCALIZATION HELD LARGEST SHARE OF ASIA PACIFIC BREAST LESION LOCALIZATION MARKET IN 2022 66
4.3 BREAST LESION LOCALIZATION MARKET (BASED ON VALUE): REGIONAL GROWTH OPPORTUNITIES 67
FIGURE 25 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN BREAST LESION LOCALIZATION MARKET DURING FORECAST PERIOD 67
4.4 BREAST LESION LOCALIZATION MARKET, BY REGION 68
FIGURE 26 NORTH AMERICA TO DOMINATE BREAST LESION LOCALIZATION MARKET TILL 2028 68
4.5 BREAST LESION LOCALIZATION MARKET: DEVELOPED VS. EMERGING ECONOMIES (USD MILLION) 69
FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 69
 
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
FIGURE 28 BREAST LESION LOCALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.2.1 DRIVERS 71
5.2.1.1 Increasing incidence of breast cancer 71
TABLE 2 TOP 10 COUNTRIES WITH HIGHEST INCIDENCE OF BREAST CANCER, 2020 71
FIGURE 29 ESTIMATED GLOBAL NUMBER OF NEW BREAST CANCER CASES (2020–2040) 72
5.2.1.2 Growth in aging population 72
5.2.1.3 Increasing awareness on early detection of breast cancer 73
5.2.2 RESTRAINTS 73
5.2.2.1 Uncertainty in regulatory approval procedures 73
5.2.3 OPPORTUNITIES 74
5.2.3.1 High growth potential in emerging economies 74
FIGURE 30 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 75
5.2.3.2 Increasing adoption of technologically advanced localization procedures 75
5.2.4 CHALLENGES 76
5.2.4.1 Shortage of oncologists 76
6 INDUSTRY INSIGHTS 77
6.1 INDUSTRY TRENDS 77
6.1.1 ELECTROMAGNETIC WAVES FOR LOCALIZATION OF BREAST LESIONS 77
6.1.2 RADIOFREQUENCY IDENTIFICATION IN BREAST LESION LOCALIZATION 77
6.1.3 MACHINE LEARNING ALGORITHMS FOR COMPUTER-AIDED BREAST LESION DETECTION 78
6.2 IMPACT OF ECONOMIC RECESSION ON BREAST LESION LOCALIZATION MARKET 78
6.3 VALUE CHAIN ANALYSIS 79
FIGURE 31 BREAST LESION LOCALIZATION MARKET: VALUE CHAIN ANALYSIS 80
6.4 REIMBURSEMENT ANALYSIS 80
TABLE 3 MEDICARE REIMBURSEMENT FOR BREAST LESION LOCALIZATION METHODS 81
6.5 TECHNOLOGY ANALYSIS 82
6.5.1 KEY TECHNOLOGIES 83
6.5.1.1 Wire-guided localization (WL) 83
6.5.1.2 Carbon marking 83
6.5.1.3 Radioguided occult lesion localization (ROLL) 83
6.5.1.4 Radioactive seed localization (RSL) 84
6.5.1.5 Magnetic seed localization (MSL) 84
6.5.1.6 Radiofrequency reflector (RFR) 84
 
6.5.2 COMPLEMENTARY TECHNOLOGIES 84
6.5.2.1 Mammography 84
6.5.2.2 3D mammography or tomosynthesis 85
6.5.2.3 Magnetic resonance imaging 85
6.5.2.4 Ultrasound 85
6.5.3 ADJACENT TECHNOLOGIES 85
6.5.3.1 Computer vision and artificial intelligence 85
6.6 SUPPLY CHAIN ANALYSIS 86
FIGURE 32 BREAST LESION LOCALIZATION MARKET: SUPPLY CHAIN ANALYSIS 87
6.7 ECOSYSTEM MARKET MAPPING 87
FIGURE 33 BREAST LESION LOCALIZATION MARKET: ECOSYSTEM MARKET MAPPING 88
6.8 CASE STUDY ANALYSIS 88
TABLE 4 CASE STUDY 1: ESTIMATING MARKET SIZE OF BREAST LESION LOCALIZATION METHODS AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL 88
TABLE 5 CASE STUDY 2: ESTIMATING MARKET SIZE OF BREAST BIOPSY AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL 89
6.9 PORTER’S FIVE FORCES ANALYSIS 89
TABLE 6 BREAST LESION LOCALIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 89
6.9.1 INTENSITY OF COMPETITIVE RIVALRY 89
6.9.2 BARGAINING POWER OF SUPPLIERS 90
6.9.3 BARGAINING POWER OF BUYERS 90
6.9.4 THREAT OF SUBSTITUTES 90
6.9.5 THREAT OF NEW ENTRANTS 90
6.10 REGULATORY ANALYSIS 91
6.10.1 NORTH AMERICA 91
6.10.1.1 US 91
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 91
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 91
6.10.1.2 Canada 92
TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 92
TABLE 10 CLASSIFICATION OF BREAST LESION LOCALIZATION DEVICES ACCORDING TO GOVERNMENT OF CANADA 92
6.10.2 EUROPE 92
FIGURE 34 EUROPE: CLASS III MEDICAL DEVICES 93
6.10.3 ASIA PACIFIC 93
6.10.3.1 India 93
6.11 PATENT ANALYSIS 94
6.11.1 PATENT PUBLICATION TRENDS FOR BREAST LESIONS 94
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2013–MAY 2023) 94
6.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BREAST LESION PATENTS (JANUARY 2013–MAY 2023) 95
FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR BREAST LESION PATENTS (JANUARY 2013–MAY 2023) 96
6.12 INDICATIVE PRICING MODEL ANALYSIS 96
TABLE 11 AVERAGE SELLING PRICE OF BREAST LESION LOCALIZATION CONSUMABLES (2023) 97
6.12.1 AVERAGE SELLING PRICE TRENDS 97
6.13 KEY CONFERENCES AND EVENTS IN 2023–2024 98
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 99
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BREAST LESION LOCALIZATION TYPE 99
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BREAST LESION LOCALIZATION TYPE 99
6.14.2 BUYING CRITERIA 100
FIGURE 39 KEY BUYING CRITERIA FOR BREAST LESION LOCALIZATION 100
TABLE 13 KEY BUYING CRITERIA FOR BREAST LESION LOCALIZATION 100
7 BREAST LESION LOCALIZATION MARKET, BY TYPE 101
7.1 INTRODUCTION 102
TABLE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 102
TABLE 15 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
7.2 WIRE LOCALIZATION 103
7.2.1 WIRE LOCALIZATION SEGMENT TO COMMAND LARGEST SHARE OF BREAST LESION LOCALIZATION MARKET 103
TABLE 16 WIRE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 104
TABLE 17 WIRE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
7.3 RADIOISOTOPE LOCALIZATION 105
TABLE 18 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 106
TABLE 19 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 20 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 107
TABLE 21 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
7.3.1 RADIOGUIDED OCCULT LESION LOCALIZATION 108
7.3.1.1 Radioguided occult lesion localization to result in shorter operating times and higher rates of tumor-free margins 108
TABLE 22 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 109
TABLE 23 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
 
7.3.2 RADIOACTIVE SEED LOCALIZATION 110
7.3.2.1 Decreased operative time and long half-life of radioactive seed localization to drive segment 110
TABLE 24 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 111
TABLE 25 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
7.4 MAGNETIC LOCALIZATION 112
7.4.1 INCREASED WORKFLOW EFFICIENCY AND COST-EFFECTIVENESS TO DRIVE MARKET 112
TABLE 26 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 113
TABLE 27 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.5 ELECTROMAGNETIC LOCALIZATION 114
7.5.1 ELECTROMAGNETIC LOCALIZATION TO ENABLE SMALLER INCISIONS DURING SURGERIES 114
TABLE 28 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 115
TABLE 29 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
7.6 OTHER LOCALIZATION TYPES 116
TABLE 30 OTHER LOCALIZATION TYPES MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 117
TABLE 31 OTHER LOCALIZATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
8 BREAST LESION LOCALIZATION MARKET, BY USAGE 119
8.1 INTRODUCTION 120
TABLE 32 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 120
TABLE 33 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 121
8.2 BREAST BIOPSY 121
8.2.1 GROWING INCIDENCE OF BREAST CANCER TO DRIVE MARKET 121
TABLE 34 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 122
TABLE 35 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2021–2028 (USD MILLION) 123
8.3 BREAST CONSERVATION (LUMPECTOMY) 123
8.3.1 INCREASING ADOPTION OF BREAST CONSERVATION PROCEDURES TO DRIVE MARKET 123
TABLE 36 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 124
TABLE 37 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2021–2028 (USD MILLION) 125
 
9 BREAST LESION LOCALIZATION MARKET, BY END USER 126
9.1 INTRODUCTION 127
TABLE 38 BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 127
TABLE 39 BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 127
9.2 HOSPITALS AND CLINICS 128
9.2.1 HOSPITALS TO PERFORM LARGE NUMBER OF BREAST LESION LOCALIZATION PROCEDURES 128
TABLE 40 BREAST LESION LOCALIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 129
TABLE 41 BREAST LESION LOCALIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 130
9.3 DIAGNOSTIC IMAGING CENTERS 130
9.3.1 INCREASED DEMAND FOR EARLY DIAGNOSIS TO DRIVE MARKET 130
TABLE 42 BREAST LESION LOCALIZATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 131
TABLE 43 BREAST LESION LOCALIZATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 132
9.4 AMBULATORY SURGICAL CENTERS 132
9.4.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 132
TABLE 44 BREAST LESION LOCALIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 133
TABLE 45 BREAST LESION LOCALIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 134
9.5 OTHER END USERS 134
TABLE 46 BREAST LESION LOCALIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 135
TABLE 47 BREAST LESION LOCALIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 136
10 BREAST LESION LOCALIZATION MARKET, BY REGION 137
10.1 INTRODUCTION 138
FIGURE 40 NUMBER OF BREAST CANCER CASES VS. NUMBER OF DEATHS IN 2020 (THOUSANDS) 138
FIGURE 41 BREAST LESION LOCALIZATION MARKET: GEOGRAPHICAL SNAPSHOT 139
TABLE 48 BREAST LESION LOCALIZATION MARKET, BY REGION, 2021–2028 (THOUSAND PROCEDURES) 139
TABLE 49 BREAST LESION LOCALIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 140
10.2 NORTH AMERICA 140
FIGURE 42 NORTH AMERICA: NUMBER OF BREAST CANCER CASES IN 2020 (THOUSANDS) 140
10.2.1 NORTH AMERICA: RECESSION IMPACT 141
TABLE 50 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 142
TABLE 51 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 52 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 142
TABLE 53 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 54 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 143
TABLE 55 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 56 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 144
TABLE 57 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 144
TABLE 58 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 145
TABLE 59 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 145
10.2.2 US 145
10.2.2.1 High adoption of innovative technologies to drive market 145
TABLE 60 US: KEY MACROINDICATORS 146
TABLE 61 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 146
TABLE 62 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 63 US: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 147
TABLE 64 US: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 65 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 148
TABLE 66 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 148
TABLE 67 US: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 148
TABLE 68 US: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.2.3 CANADA 149
10.2.3.1 Supportive government initiatives for breast cancer awareness to drive market 149
TABLE 69 CANADA: KEY MACROINDICATORS 150
TABLE 70 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 150
TABLE 71 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 72 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 151
TABLE 73 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 74 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 152
TABLE 75 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 152
TABLE 76 CANADA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 152
TABLE 77 CANADA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.3 EUROPE 153
FIGURE 44 EUROPE: NUMBER OF BREAST CANCER CASES IN 2020 (THOUSANDS) 154
10.3.1 EUROPE: RECESSION IMPACT 154
TABLE 78 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 156
TABLE 79 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 80 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 157
TABLE 81 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 82 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 158
TABLE 83 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 84 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 158
TABLE 85 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 159
TABLE 86 EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 159
TABLE 87 EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.3.2 GERMANY 160
10.3.2.1 Favorable reimbursement policies for healthcare procedures to drive market 160
TABLE 88 GERMANY: KEY MACROINDICATORS 161
TABLE 89 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 161
TABLE 90 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 91 GERMANY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 162
TABLE 92 GERMANY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 93 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 163
TABLE 94 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 163
TABLE 95 GERMANY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 163
TABLE 96 GERMANY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 164
10.3.3 FRANCE 164
10.3.3.1 Rising incidences of breast cancer among aged women to drive market 164
TABLE 97 FRANCE: KEY MACROINDICATORS 165
TABLE 98 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 165
TABLE 99 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 100 FRANCE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 166
TABLE 101 FRANCE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 102 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 167
TABLE 103 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 167
TABLE 104 FRANCE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 167
TABLE 105 FRANCE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.3.4 UK 168
10.3.4.1 Increasing public-private initiatives for breast cancer awareness to drive market 168
TABLE 106 UK: KEY MACROINDICATORS 169
TABLE 107 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 169
TABLE 108 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 109 UK: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 170
TABLE 110 UK: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 111 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 171
TABLE 112 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 171
TABLE 113 UK: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 171
TABLE 114 UK: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.3.5 ITALY 172
10.3.5.1 Increasing demand for breast lesion localization systems to drive market 172
TABLE 115 ITALY: KEY MACROINDICATORS 173
TABLE 116 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 173
TABLE 117 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 118 ITALY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 174
TABLE 119 ITALY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 120 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 175
TABLE 121 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 175
TABLE 122 ITALY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 175
TABLE 123 ITALY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.3.6 SPAIN 176
10.3.6.1 Growing access to advanced cancer screening programs to drive market 176
TABLE 124 SPAIN: KEY MACROINDICATORS 177
TABLE 125 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 177
TABLE 126 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 127 SPAIN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 178
TABLE 128 SPAIN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 129 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 179
TABLE 130 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 179
TABLE 131 SPAIN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 179
TABLE 132 SPAIN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 180
10.3.7 REST OF EUROPE 180
TABLE 133 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 180
TABLE 134 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 135 REST OF EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 181
TABLE 136 REST OF EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 137 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 182
TABLE 138 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 182
TABLE 139 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 183
TABLE 140 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10.4 ASIA PACIFIC 184
FIGURE 46 ASIA PACIFIC: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS) 184
10.4.1 ASIA PACIFIC: RECESSION IMPACT 184
TABLE 141 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 186
TABLE 142 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 143 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 187
TABLE 144 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 145 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 188
TABLE 146 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 147 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 188
TABLE 148 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 189
TABLE 149 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 189
TABLE 150 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 190
10.4.2 CHINA 190
10.4.2.1 Increasing patient pool and developing government healthcare initiatives to drive market 190
TABLE 151 CHINA: KEY MACROINDICATORS 191
TABLE 152 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 191
TABLE 153 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 154 CHINA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 192
TABLE 155 CHINA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 156 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 193
TABLE 157 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 193
TABLE 158 CHINA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 194
TABLE 159 CHINA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 194
10.4.3 JAPAN 195
10.4.3.1 Increasing number of universal healthcare reimbursement policies to drive market 195
TABLE 160 JAPAN: KEY MACROINDICATORS 195
TABLE 161 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 196
TABLE 162 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 163 JAPAN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 197
TABLE 164 JAPAN: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 165 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 197
TABLE 166 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 198
TABLE 167 JAPAN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 198
TABLE 168 JAPAN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 199
10.4.4 INDIA 199
10.4.4.1 Increasing government Initiatives for female health improvement to drive market 199
TABLE 169 INDIA: KEY MACROINDICATORS 200
TABLE 170 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 200
TABLE 171 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 172 INDIA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 201
TABLE 173 INDIA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 174 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 202
TABLE 175 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 202
TABLE 176 INDIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 203
TABLE 177 INDIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 203
10.4.5 AUSTRALIA 203
10.4.5.1 Growing breast cancer awareness campaigns by public and private organizations to drive market 203
TABLE 178 AUSTRALIA: KEY MACROINDICATORS 204
TABLE 179 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 204
TABLE 180 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 181 AUSTRALIA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 205
TABLE 182 AUSTRALIA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 183 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 206
TABLE 184 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 206
TABLE 185 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 207
TABLE 186 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 207
10.4.6 SOUTH KOREA 207
10.4.6.1 Growing government awareness campaigns and rising incidences of breast cancer to drive market 207
TABLE 187 SOUTH KOREA: KEY MACROINDICATORS 208
TABLE 188 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 208
TABLE 189 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 190 SOUTH KOREA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 209
TABLE 191 SOUTH KOREA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 192 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 210
TABLE 193 SOUTH KOREA: BREAST LESION LOCALIZATION PRODUCTS MARKET, BY USAGE, 2021–2028 (USD MILLION) 210
TABLE 194 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 211
TABLE 195 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 211
10.4.7 REST OF ASIA PACIFIC 211
TABLE 196 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 212
TABLE 197 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 198 REST OF ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 213
TABLE 199 REST OF ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 200 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 213
TABLE 201 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 214
TABLE 202 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 214
TABLE 203 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 215
10.5 LATIN AMERICA 215
10.5.1 RISING GERIATRIC POPULATION AND PRESENCE OF FAVORABLE REGULATORY ENVIRONMENT TO DRIVE MARKET 215
10.5.2 LATIN AMERICA: RECESSION IMPACT 216
TABLE 204 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 216
TABLE 205 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 206 LATIN AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 217
TABLE 207 LATIN AMERICA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 208 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 218
TABLE 209 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 218
TABLE 210 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 219
TABLE 211 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 219
10.6 MIDDLE EAST & AFRICA 220
10.6.1 RISING GOVERNMENT INVESTMENTS AND INCREASING BREAST CANCER AWARENESS PROGRAMS TO DRIVE MARKET 220
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 220
TABLE 212 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 221
TABLE 213 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 214 MIDDLE EAST & AFRICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 222
TABLE 215 MIDDLE EAST & AFRICA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 216 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 222
TABLE 217 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 223
TABLE 218 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 223
TABLE 219 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 224

　

ページTOPに戻る


　

Summary

The global breast lesion localization market is projected to reach USD 0.4 billion by 2028 from USD 0.3 billion in 2023, at a CAGR of 6.9% during the forecast period. The increasing screening of breast cancer through mammography and the increasing number of improvements in imaging technology have increased the detection of a non-palpable clinically occult breast lesion, which requires perioperative localization.
There have been several technological advancements in breast lesion localization equipment in recent years aimed at improving patient safety, increasing efficiency, and reducing the cost of healthcare.

“Breast biopsy segment accounted for a larger share of the breast lesion localization market”

In 2022, the breast biopsy segment accounted for a larger share of the breast lesion localization market. The large share of this segment can be attributed to the increasing number of patients opting for breast biopsies across the world, the increasing rate of non-palpable breast lesions detected in screening programs, the rising number of breast cancer screening programs, the growing incidence of breast cancer, and an increase in awareness of early cancer detection.

“The electromagnetic localization will grow at highest CAGR during the forecast period”

Based on type, the electromagnetic localization segment is estimated to grow at the highest during the forecast period. The high growth of this segment can be attributed to factors such as reduction in surgical delays, improved patient satisfaction, optimal surgical planning, and no need for radioactive components. A recent development in the field of breast localization methods is the emergence of technologically advanced localization methods, which use electromagnetic waves to localize breast lesions.

“Asia Pacific will grow at highest CAGR during the forecast period”

In 2022, Asia Pacific will grow at highest CAGR during the forecast period. Major factors driving the growth of this market are rising prevalence of breast cancer, increasing healthcare expenditure, and the increasing number of awareness programs for the early detection of breast cancer in several APAC countries. Furthermore, rising government spending on breast cancer research, and growing funding are also driving the market growth in APAC.

The break-up of the profile of primary participants in the breast lesion localization market: Supply-side

• By Company Type: Tier 1 – 55%, Tier 2 – 30%, and Tier 3 – 15%
• By Designation: C Level – 28%, Hospital Director & Managers – 33%, Others-39%
• By Region: North America – 35%, Europe – 20%, Asia Pacific – 30%, Middle East – 9%, and Latin America – 6%

The break-up of the profile of primary participants in the breast lesion localization market: Demand-side

• By End User: Hospitals – 55%, Clinics – 32%, and Ambulatory Surgical Centers – 13%
• By Designation: Doctors – 35%, Hospitals, Directors and Mangers – 27%, Critical Care Specialist-22% Others-16%
• By Region: North America – 17%, Europe – 39%, Asia Pacific – 28%, Middle East – 8%, and Latin America – 8%

The prominent players in the breast lesion localization market include Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US).
Research Coverage:
The report analyzes the breast lesion localization market and aims at estimating the market size and future growth potential of this market based on various segments such as type, usage, end user and region. The report also includes a product portfolio matrix of various breast lesion localization available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall breast lesion localization market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:

• Analysis of key drivers (increasing incidence of breast cancer, growing rate of the aging population, increasing awareness on the early detection of breast cancer), restraints (uncertainty in regulatory approval procedures), opportunities (emerging economies offer high growth potential and increasing adoption of technologically advanced localization procedures), and challenges (shortage of oncologists) influencing the growth of the breast lesion localization market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the breast lesion localization market
• Market Development: Comprehensive information on the lucrative emerging markets by type, usage, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global breast lesion localization market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US) in the global breast lesion localization market.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 36
1.1 STUDY OBJECTIVES 36
1.2 MARKET DEFINITION 36
1.3 INCLUSIONS AND EXCLUSIONS 37
1.4 STUDY SCOPE 38
1.4.1 MARKETS COVERED 38
FIGURE 1 MARKET SEGMENTATION 38
1.4.2 YEARS CONSIDERED 38
1.5 CURRENCY CONSIDERED 39
1.6 STAKEHOLDERS 39
1.7 SUMMARY OF CHANGES 39
1.8 RECESSION IMPACT: BREAST LESION LOCALIZATION MARKET 40
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
FIGURE 2 RESEARCH DESIGN 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY DATA 43
FIGURE 3 PRIMARY SOURCES 44
2.1.2.1 Key data from primary sources 45
2.1.2.2 Key industry insights 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46
2.2 MARKET SIZE ESTIMATION 47
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 48
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: HOLOGIC, INC. 48
FIGURE 8 BREAST LESION LOCALIZATION MARKET: REVENUE SHARE ANALYSIS OF FOUR KEY COMPANIES (2022) 49
FIGURE 9 BREAST LESION LOCALIZATION MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
2.2.1 MARKET SEGMENT ASSESSMENT (BY TYPE, USAGE, AND END USER) 52
FIGURE 11 TOP-DOWN APPROACH 52
2.2.2 GEOGRAPHICAL MARKET ASSESSMENT (BY REGION AND COUNTRY) 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 12 DATA TRIANGULATION METHODOLOGY 53
2.4 STUDY ASSUMPTIONS 54
2.5 RISK ASSESSMENT 54
TABLE 1 BREAST LESION LOCALIZATION MARKET: RISK ASSESSMENT ANALYSIS 54
2.6 RESEARCH LIMITATIONS 55
2.6.1 METHODOLOGY-RELATED LIMITATIONS 55
2.6.2 SCOPE-RELATED LIMITATIONS 55
3 EXECUTIVE SUMMARY 56
FIGURE 13 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 56
FIGURE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 15 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (THOUSAND PROCEDURES) 58
FIGURE 16 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 58
FIGURE 17 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2023 VS. 2028 (THOUSAND PROCEDURES) 59
FIGURE 18 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 19 BREAST LESION LOCALIZATION MARKET, BY END USER, 2023 VS. 2028 (THOUSAND PROCEDURES) 60
FIGURE 20 BREAST LESION LOCALIZATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 61
FIGURE 21 GEOGRAPHICAL ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (PROCEDURES) 62
FIGURE 22 GEOGRAPHICAL ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (VALUE) 63
4 PREMIUM INSIGHTS 65
4.1 BREAST LESION LOCALIZATION MARKET OVERVIEW 65
FIGURE 23 RISING AWARENESS ABOUT BREAST CANCER AND INCREASING GOVERNMENT INITIATIVES GLOBALLY TO DRIVE MARKET 65
4.2 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE 66
FIGURE 24 WIRE LOCALIZATION HELD LARGEST SHARE OF ASIA PACIFIC BREAST LESION LOCALIZATION MARKET IN 2022 66
4.3 BREAST LESION LOCALIZATION MARKET (BASED ON VALUE): REGIONAL GROWTH OPPORTUNITIES 67
FIGURE 25 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN BREAST LESION LOCALIZATION MARKET DURING FORECAST PERIOD 67
4.4 BREAST LESION LOCALIZATION MARKET, BY REGION 68
FIGURE 26 NORTH AMERICA TO DOMINATE BREAST LESION LOCALIZATION MARKET TILL 2028 68
4.5 BREAST LESION LOCALIZATION MARKET: DEVELOPED VS. EMERGING ECONOMIES (USD MILLION) 69
FIGURE 27 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD 69
 
5 MARKET OVERVIEW 70
5.1 INTRODUCTION 70
5.2 MARKET DYNAMICS 70
FIGURE 28 BREAST LESION LOCALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 70
5.2.1 DRIVERS 71
5.2.1.1 Increasing incidence of breast cancer 71
TABLE 2 TOP 10 COUNTRIES WITH HIGHEST INCIDENCE OF BREAST CANCER, 2020 71
FIGURE 29 ESTIMATED GLOBAL NUMBER OF NEW BREAST CANCER CASES (2020–2040) 72
5.2.1.2 Growth in aging population 72
5.2.1.3 Increasing awareness on early detection of breast cancer 73
5.2.2 RESTRAINTS 73
5.2.2.1 Uncertainty in regulatory approval procedures 73
5.2.3 OPPORTUNITIES 74
5.2.3.1 High growth potential in emerging economies 74
FIGURE 30 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 75
5.2.3.2 Increasing adoption of technologically advanced localization procedures 75
5.2.4 CHALLENGES 76
5.2.4.1 Shortage of oncologists 76
6 INDUSTRY INSIGHTS 77
6.1 INDUSTRY TRENDS 77
6.1.1 ELECTROMAGNETIC WAVES FOR LOCALIZATION OF BREAST LESIONS 77
6.1.2 RADIOFREQUENCY IDENTIFICATION IN BREAST LESION LOCALIZATION 77
6.1.3 MACHINE LEARNING ALGORITHMS FOR COMPUTER-AIDED BREAST LESION DETECTION 78
6.2 IMPACT OF ECONOMIC RECESSION ON BREAST LESION LOCALIZATION MARKET 78
6.3 VALUE CHAIN ANALYSIS 79
FIGURE 31 BREAST LESION LOCALIZATION MARKET: VALUE CHAIN ANALYSIS 80
6.4 REIMBURSEMENT ANALYSIS 80
TABLE 3 MEDICARE REIMBURSEMENT FOR BREAST LESION LOCALIZATION METHODS 81
6.5 TECHNOLOGY ANALYSIS 82
6.5.1 KEY TECHNOLOGIES 83
6.5.1.1 Wire-guided localization (WL) 83
6.5.1.2 Carbon marking 83
6.5.1.3 Radioguided occult lesion localization (ROLL) 83
6.5.1.4 Radioactive seed localization (RSL) 84
6.5.1.5 Magnetic seed localization (MSL) 84
6.5.1.6 Radiofrequency reflector (RFR) 84
 
6.5.2 COMPLEMENTARY TECHNOLOGIES 84
6.5.2.1 Mammography 84
6.5.2.2 3D mammography or tomosynthesis 85
6.5.2.3 Magnetic resonance imaging 85
6.5.2.4 Ultrasound 85
6.5.3 ADJACENT TECHNOLOGIES 85
6.5.3.1 Computer vision and artificial intelligence 85
6.6 SUPPLY CHAIN ANALYSIS 86
FIGURE 32 BREAST LESION LOCALIZATION MARKET: SUPPLY CHAIN ANALYSIS 87
6.7 ECOSYSTEM MARKET MAPPING 87
FIGURE 33 BREAST LESION LOCALIZATION MARKET: ECOSYSTEM MARKET MAPPING 88
6.8 CASE STUDY ANALYSIS 88
TABLE 4 CASE STUDY 1: ESTIMATING MARKET SIZE OF BREAST LESION LOCALIZATION METHODS AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL 88
TABLE 5 CASE STUDY 2: ESTIMATING MARKET SIZE OF BREAST BIOPSY AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL 89
6.9 PORTER’S FIVE FORCES ANALYSIS 89
TABLE 6 BREAST LESION LOCALIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS 89
6.9.1 INTENSITY OF COMPETITIVE RIVALRY 89
6.9.2 BARGAINING POWER OF SUPPLIERS 90
6.9.3 BARGAINING POWER OF BUYERS 90
6.9.4 THREAT OF SUBSTITUTES 90
6.9.5 THREAT OF NEW ENTRANTS 90
6.10 REGULATORY ANALYSIS 91
6.10.1 NORTH AMERICA 91
6.10.1.1 US 91
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 91
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 91
6.10.1.2 Canada 92
TABLE 9 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 92
TABLE 10 CLASSIFICATION OF BREAST LESION LOCALIZATION DEVICES ACCORDING TO GOVERNMENT OF CANADA 92
6.10.2 EUROPE 92
FIGURE 34 EUROPE: CLASS III MEDICAL DEVICES 93
6.10.3 ASIA PACIFIC 93
6.10.3.1 India 93
6.11 PATENT ANALYSIS 94
6.11.1 PATENT PUBLICATION TRENDS FOR BREAST LESIONS 94
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2013–MAY 2023) 94
6.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 95
FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BREAST LESION PATENTS (JANUARY 2013–MAY 2023) 95
FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR BREAST LESION PATENTS (JANUARY 2013–MAY 2023) 96
6.12 INDICATIVE PRICING MODEL ANALYSIS 96
TABLE 11 AVERAGE SELLING PRICE OF BREAST LESION LOCALIZATION CONSUMABLES (2023) 97
6.12.1 AVERAGE SELLING PRICE TRENDS 97
6.13 KEY CONFERENCES AND EVENTS IN 2023–2024 98
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA 99
6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BREAST LESION LOCALIZATION TYPE 99
TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR BREAST LESION LOCALIZATION TYPE 99
6.14.2 BUYING CRITERIA 100
FIGURE 39 KEY BUYING CRITERIA FOR BREAST LESION LOCALIZATION 100
TABLE 13 KEY BUYING CRITERIA FOR BREAST LESION LOCALIZATION 100
7 BREAST LESION LOCALIZATION MARKET, BY TYPE 101
7.1 INTRODUCTION 102
TABLE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 102
TABLE 15 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
7.2 WIRE LOCALIZATION 103
7.2.1 WIRE LOCALIZATION SEGMENT TO COMMAND LARGEST SHARE OF BREAST LESION LOCALIZATION MARKET 103
TABLE 16 WIRE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 104
TABLE 17 WIRE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
7.3 RADIOISOTOPE LOCALIZATION 105
TABLE 18 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 106
TABLE 19 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 20 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 107
TABLE 21 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
7.3.1 RADIOGUIDED OCCULT LESION LOCALIZATION 108
7.3.1.1 Radioguided occult lesion localization to result in shorter operating times and higher rates of tumor-free margins 108
TABLE 22 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 109
TABLE 23 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
 
7.3.2 RADIOACTIVE SEED LOCALIZATION 110
7.3.2.1 Decreased operative time and long half-life of radioactive seed localization to drive segment 110
TABLE 24 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 111
TABLE 25 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
7.4 MAGNETIC LOCALIZATION 112
7.4.1 INCREASED WORKFLOW EFFICIENCY AND COST-EFFECTIVENESS TO DRIVE MARKET 112
TABLE 26 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 113
TABLE 27 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.5 ELECTROMAGNETIC LOCALIZATION 114
7.5.1 ELECTROMAGNETIC LOCALIZATION TO ENABLE SMALLER INCISIONS DURING SURGERIES 114
TABLE 28 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 115
TABLE 29 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
7.6 OTHER LOCALIZATION TYPES 116
TABLE 30 OTHER LOCALIZATION TYPES MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 117
TABLE 31 OTHER LOCALIZATION TYPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
8 BREAST LESION LOCALIZATION MARKET, BY USAGE 119
8.1 INTRODUCTION 120
TABLE 32 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 120
TABLE 33 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 121
8.2 BREAST BIOPSY 121
8.2.1 GROWING INCIDENCE OF BREAST CANCER TO DRIVE MARKET 121
TABLE 34 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 122
TABLE 35 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2021–2028 (USD MILLION) 123
8.3 BREAST CONSERVATION (LUMPECTOMY) 123
8.3.1 INCREASING ADOPTION OF BREAST CONSERVATION PROCEDURES TO DRIVE MARKET 123
TABLE 36 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 124
TABLE 37 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2021–2028 (USD MILLION) 125
 
9 BREAST LESION LOCALIZATION MARKET, BY END USER 126
9.1 INTRODUCTION 127
TABLE 38 BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 127
TABLE 39 BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 127
9.2 HOSPITALS AND CLINICS 128
9.2.1 HOSPITALS TO PERFORM LARGE NUMBER OF BREAST LESION LOCALIZATION PROCEDURES 128
TABLE 40 BREAST LESION LOCALIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 129
TABLE 41 BREAST LESION LOCALIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 130
9.3 DIAGNOSTIC IMAGING CENTERS 130
9.3.1 INCREASED DEMAND FOR EARLY DIAGNOSIS TO DRIVE MARKET 130
TABLE 42 BREAST LESION LOCALIZATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 131
TABLE 43 BREAST LESION LOCALIZATION MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 132
9.4 AMBULATORY SURGICAL CENTERS 132
9.4.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 132
TABLE 44 BREAST LESION LOCALIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 133
TABLE 45 BREAST LESION LOCALIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 134
9.5 OTHER END USERS 134
TABLE 46 BREAST LESION LOCALIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 135
TABLE 47 BREAST LESION LOCALIZATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 136
10 BREAST LESION LOCALIZATION MARKET, BY REGION 137
10.1 INTRODUCTION 138
FIGURE 40 NUMBER OF BREAST CANCER CASES VS. NUMBER OF DEATHS IN 2020 (THOUSANDS) 138
FIGURE 41 BREAST LESION LOCALIZATION MARKET: GEOGRAPHICAL SNAPSHOT 139
TABLE 48 BREAST LESION LOCALIZATION MARKET, BY REGION, 2021–2028 (THOUSAND PROCEDURES) 139
TABLE 49 BREAST LESION LOCALIZATION MARKET, BY REGION, 2021–2028 (USD MILLION) 140
10.2 NORTH AMERICA 140
FIGURE 42 NORTH AMERICA: NUMBER OF BREAST CANCER CASES IN 2020 (THOUSANDS) 140
10.2.1 NORTH AMERICA: RECESSION IMPACT 141
TABLE 50 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 142
TABLE 51 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 52 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 142
TABLE 53 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 54 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 143
TABLE 55 NORTH AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 56 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 144
TABLE 57 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 144
TABLE 58 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 145
TABLE 59 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 145
10.2.2 US 145
10.2.2.1 High adoption of innovative technologies to drive market 145
TABLE 60 US: KEY MACROINDICATORS 146
TABLE 61 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 146
TABLE 62 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 63 US: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 147
TABLE 64 US: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 65 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 148
TABLE 66 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 148
TABLE 67 US: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 148
TABLE 68 US: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 149
10.2.3 CANADA 149
10.2.3.1 Supportive government initiatives for breast cancer awareness to drive market 149
TABLE 69 CANADA: KEY MACROINDICATORS 150
TABLE 70 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 150
TABLE 71 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 72 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 151
TABLE 73 CANADA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 74 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 152
TABLE 75 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 152
TABLE 76 CANADA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 152
TABLE 77 CANADA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.3 EUROPE 153
FIGURE 44 EUROPE: NUMBER OF BREAST CANCER CASES IN 2020 (THOUSANDS) 154
10.3.1 EUROPE: RECESSION IMPACT 154
TABLE 78 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 156
TABLE 79 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 80 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 157
TABLE 81 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 82 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 158
TABLE 83 EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 84 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 158
TABLE 85 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 159
TABLE 86 EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 159
TABLE 87 EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 160
10.3.2 GERMANY 160
10.3.2.1 Favorable reimbursement policies for healthcare procedures to drive market 160
TABLE 88 GERMANY: KEY MACROINDICATORS 161
TABLE 89 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 161
TABLE 90 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 91 GERMANY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 162
TABLE 92 GERMANY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 93 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 163
TABLE 94 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 163
TABLE 95 GERMANY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 163
TABLE 96 GERMANY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 164
10.3.3 FRANCE 164
10.3.3.1 Rising incidences of breast cancer among aged women to drive market 164
TABLE 97 FRANCE: KEY MACROINDICATORS 165
TABLE 98 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 165
TABLE 99 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 100 FRANCE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 166
TABLE 101 FRANCE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 102 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 167
TABLE 103 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 167
TABLE 104 FRANCE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 167
TABLE 105 FRANCE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.3.4 UK 168
10.3.4.1 Increasing public-private initiatives for breast cancer awareness to drive market 168
TABLE 106 UK: KEY MACROINDICATORS 169
TABLE 107 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 169
TABLE 108 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 109 UK: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 170
TABLE 110 UK: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 111 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 171
TABLE 112 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 171
TABLE 113 UK: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 171
TABLE 114 UK: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.3.5 ITALY 172
10.3.5.1 Increasing demand for breast lesion localization systems to drive market 172
TABLE 115 ITALY: KEY MACROINDICATORS 173
TABLE 116 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 173
TABLE 117 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 118 ITALY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 174
TABLE 119 ITALY: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 120 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 175
TABLE 121 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 175
TABLE 122 ITALY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 175
TABLE 123 ITALY: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.3.6 SPAIN 176
10.3.6.1 Growing access to advanced cancer screening programs to drive market 176
TABLE 124 SPAIN: KEY MACROINDICATORS 177
TABLE 125 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 177
TABLE 126 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 127 SPAIN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 178
TABLE 128 SPAIN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 129 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 179
TABLE 130 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 179
TABLE 131 SPAIN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 179
TABLE 132 SPAIN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 180
10.3.7 REST OF EUROPE 180
TABLE 133 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 180
TABLE 134 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 135 REST OF EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 181
TABLE 136 REST OF EUROPE: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 137 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 182
TABLE 138 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 182
TABLE 139 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 183
TABLE 140 REST OF EUROPE: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10.4 ASIA PACIFIC 184
FIGURE 46 ASIA PACIFIC: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS) 184
10.4.1 ASIA PACIFIC: RECESSION IMPACT 184
TABLE 141 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (THOUSAND PROCEDURES) 186
TABLE 142 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 143 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 187
TABLE 144 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 145 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 188
TABLE 146 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 147 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 188
TABLE 148 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 189
TABLE 149 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 189
TABLE 150 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 190
10.4.2 CHINA 190
10.4.2.1 Increasing patient pool and developing government healthcare initiatives to drive market 190
TABLE 151 CHINA: KEY MACROINDICATORS 191
TABLE 152 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 191
TABLE 153 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 192
TABLE 154 CHINA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 192
TABLE 155 CHINA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 156 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 193
TABLE 157 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 193
TABLE 158 CHINA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 194
TABLE 159 CHINA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 194
10.4.3 JAPAN 195
10.4.3.1 Increasing number of universal healthcare reimbursement policies to drive market 195
TABLE 160 JAPAN: KEY MACROINDICATORS 195
TABLE 161 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 196
TABLE 162 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 163 JAPAN: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 197
TABLE 164 JAPAN: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 165 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 197
TABLE 166 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 198
TABLE 167 JAPAN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 198
TABLE 168 JAPAN: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 199
10.4.4 INDIA 199
10.4.4.1 Increasing government Initiatives for female health improvement to drive market 199
TABLE 169 INDIA: KEY MACROINDICATORS 200
TABLE 170 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 200
TABLE 171 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 172 INDIA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 201
TABLE 173 INDIA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 174 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 202
TABLE 175 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 202
TABLE 176 INDIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 203
TABLE 177 INDIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 203
10.4.5 AUSTRALIA 203
10.4.5.1 Growing breast cancer awareness campaigns by public and private organizations to drive market 203
TABLE 178 AUSTRALIA: KEY MACROINDICATORS 204
TABLE 179 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 204
TABLE 180 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 181 AUSTRALIA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 205
TABLE 182 AUSTRALIA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 183 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 206
TABLE 184 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 206
TABLE 185 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 207
TABLE 186 AUSTRALIA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 207
10.4.6 SOUTH KOREA 207
10.4.6.1 Growing government awareness campaigns and rising incidences of breast cancer to drive market 207
TABLE 187 SOUTH KOREA: KEY MACROINDICATORS 208
TABLE 188 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 208
TABLE 189 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 190 SOUTH KOREA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 209
TABLE 191 SOUTH KOREA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 192 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 210
TABLE 193 SOUTH KOREA: BREAST LESION LOCALIZATION PRODUCTS MARKET, BY USAGE, 2021–2028 (USD MILLION) 210
TABLE 194 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 211
TABLE 195 SOUTH KOREA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 211
10.4.7 REST OF ASIA PACIFIC 211
TABLE 196 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 212
TABLE 197 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 212
TABLE 198 REST OF ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 213
TABLE 199 REST OF ASIA PACIFIC: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 200 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 213
TABLE 201 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 214
TABLE 202 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 214
TABLE 203 REST OF ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 215
10.5 LATIN AMERICA 215
10.5.1 RISING GERIATRIC POPULATION AND PRESENCE OF FAVORABLE REGULATORY ENVIRONMENT TO DRIVE MARKET 215
10.5.2 LATIN AMERICA: RECESSION IMPACT 216
TABLE 204 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 216
TABLE 205 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 206 LATIN AMERICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 217
TABLE 207 LATIN AMERICA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 208 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 218
TABLE 209 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 218
TABLE 210 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 219
TABLE 211 LATIN AMERICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 219
10.6 MIDDLE EAST & AFRICA 220
10.6.1 RISING GOVERNMENT INVESTMENTS AND INCREASING BREAST CANCER AWARENESS PROGRAMS TO DRIVE MARKET 220
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 220
TABLE 212 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 221
TABLE 213 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 214 MIDDLE EAST & AFRICA: RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021–2028 (THOUSAND PROCEDURES) 222
TABLE 215 MIDDLE EAST & AFRICA: RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 216 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (THOUSAND PROCEDURES) 222
TABLE 217 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021–2028 (USD MILLION) 223
TABLE 218 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (THOUSAND PROCEDURES) 223
TABLE 219 MIDDLE EAST & AFRICA: BREAST LESION LOCALIZATION MARKET, BY END USER, 2021–2028 (USD MILLION) 224

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

MarketsandMarkets社のMedical Devices分野での最新刊レポート

本レポートと同じKEY WORD（wire）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18　10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.